Abstract
Background
Evidence of endoscopic papillectomy (EP) for ampullar adenoma with high-grade dysplasia (HGD) or adenocarcinoma is insufficient. Here we investigated the long-term outcomes of the advanced ampullary tumors treated by EP with careful surveillance comparing to subsequent surgery after EP.
Methods
Patients treated with EP for ampullary adenoma with HGD or adenocarcinoma from the multi-center retrospective Korean cohort of ampulla of Vater tumor were categorized into EP alone versus EP with subsequent surgery groups. The overall survival (OS) and recurrence-free survival (RFS) were analyzed for unmatched and matched cohorts using propensity score with nearest neighbor method.
Results
During a median 43.3 months of follow-up, 5-year OS was not significantly different between the EP alone and EP surgery groups (91.9% vs. 82.3%, P = 0.443 for unmatched cohort; 89.2% vs. 82.3%, P = 0.861 for matched cohort, respectively). Furthermore, 5-year RFS was not significantly different between the two groups (82.1% vs. 86.7%, P = 0.520 for unmatched cohort; 66.1% vs. 86.7%, P = 0.052 for matched cohort, respectively). However, the patients with positive both (lateral and deep) margins showed significantly poorer survival outcomes than those with negative margins within the EP alone group (P = 0.007).
Conclusion
EP alone with careful surveillance showed comparable survival outcomes to those of EP with subsequent surgery for ampullar HGD or adenocarcinoma. Resection margin status could be a parameter to determine whether to perform subsequent radical surgery after EP.
Graphical abstract
Similar content being viewed by others
References
Suzuki K (1983) Two cases of endoscopically resected tumor of the duodenal papilla. Prog Dig Endosc 23:236–239
Kang SH, Kim KH, Kim TN, Jung MK, Cho CM, Cho KB, Han JM, Kim HG, Kim HS (2017) Therapeutic outcomes of endoscopic papillectomy for ampullary neoplasms: retrospective analysis of a multicenter study. BMC Gastroenterol 17:69
Vanbiervliet G, Strijker M, Arvanitakis M, Aelvoet A, Arnelo U, Beyna T, Busch O, Deprez PH, Kunovsky L, Larghi A, Manes G, Moss A, Napoleon B, Nayar M, Perez-Cuadrado-Robles E, Seewald S, Barthet M, van Hooft JE (2021) Endoscopic management of ampullary tumors: European society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy 53:429–448
Committee ASOP, Chathadi KV, Khashab MA, Acosta RD, Chandrasekhara V, Eloubeidi MA, Faulx AL, Fonkalsrud L, Lightdale JR, Salztman JR, Shaukat A, Wang A, Cash BD, DeWitt JM (2015) The role of endoscopy in ampullary and duodenal adenomas. Gastrointest Endosc 82:773–781
Itoi T, Ryozawa S, Katanuma A, Kawashima H, Iwasaki E, Hashimoto S, Yamamoto K, Ueki T, Igarashi Y, Inui K, Fujita N, Fujimoto K (2022) Clinical practice guidelines for endoscopic papillectomy. Dig Endosc 34:394–411
Winter JM, Cameron JL, Olino K, Herman JM, de Jong MC, Hruban RH, Wolfgang CL, Eckhauser F, Edil BH, Choti MA, Schulick RD, Pawlik TM (2010) Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis. J Gastrointest Surg 14:379–387
Yamamoto K, Iwasaki E, Itoi T (2020) Insights and updates on endoscopic papillectomy. Expert Rev Gastroenterol Hepatol 14:435–444
Heise C, Abou Ali E, Hasenclever D, Auriemma F, Gulla A, Regner S, Gaujoux S, Hollenbach M (2020) Systematic review with meta-analysis: endoscopic and surgical resection for ampullary lesions. J Clin Med 9:3622
Yoon SM, Kim MH, Kim MJ, Jang SJ, Lee TY, Kwon S, Oh HC, Lee SS, Seo DW, Lee SK (2007) Focal early stage cancer in ampullary adenoma: surgery or endoscopic papillectomy? Gastrointest Endosc 66:701–707
Woo SM, Ryu JK, Lee SH, Lee WJ, Hwang JH, Yoo JW, Park JK, Kang GH, Kim YT, Yoon YB (2009) Feasibility of endoscopic papillectomy in early stage ampulla of Vater cancer. J Gastroenterol Hepatol 24:120–124
Yamamoto K, Itoi T, Sofuni A, Tsuchiya T, Tanaka R, Tonozuka R, Honjo M, Mukai S, Fujita M, Asai Y, Matsunami Y, Kurosawa T, Yamaguchi H, Nagakawa Y (2019) Expanding the indication of endoscopic papillectomy for T1a ampullary carcinoma. Dig Endosc 31:188–196
Hwang JS, So H, Oh D, Song TJ, Park DH, Seo DW, Lee SK, Kim MH, Hong SM, Yang J, Lee SS (2021) Long-term outcomes of endoscopic papillectomy for early-stage cancer in duodenal ampullary adenoma: comparison to surgical treatment. J Gastroenterol Hepatol 36:2315–2323
Lee SY, Jang KT, Lee KT, Lee JK, Choi SH, Heo JS, Paik SW, Rhee JC (2006) Can endoscopic resection be applied for early stage ampulla of Vater cancer? Gastrointest Endosc 63:783–788
Petrone G, Ricci R, Familiari P, Inzani F, Matsuoka M, Mutignani M, Delle Fave G, Costamagna G, Rindi G (2013) Endoscopic snare papillectomy: a possible radical treatment for a subgroup of T1 ampullary adenocarcinomas. Endoscopy 45:401–404
Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC, Mergener K, Nemcek A Jr, Petersen BT, Petrini JL, Pike IM, Rabeneck L, Romagnuolo J, Vargo JJ (2010) A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 71:446–454
Committee ASOP, Chandrasekhara V, Khashab MA, Muthusamy VR, Acosta RD, Agrawal D, Bruining DH, Eloubeidi MA, Fanelli RD, Faulx AL, Gurudu SR, Kothari S, Lightdale JR, Qumseya BJ, Shaukat A, Wang A, Wani SB, Yang J, DeWitt JM (2017) Adverse events associated with ERCP. Gastrointest Endosc 85:32–47
Yang C, Wu HS, Chen XL, Wang CY, Gou SM, Xiao J, He ZQ, Chen QJ, Li YF (2014) Pylorus-preserving versus pylorus-resecting pancreaticoduodenectomy for periampullary and pancreatic carcinoma: a meta-analysis. PLoS ONE 9:e90316
Salmi S, Ezzedine S, Vitton V, Menard C, Gonzales JM, Desjeux A, Grimaud JC, Barthet M (2012) Can papillary carcinomas be treated by endoscopic ampullectomy? Surg Endosc 26:920–925
Napoleon B, Gincul R, Ponchon T, Berthiller J, Escourrou J, Canard JM, Boyer J, Barthet M, Ponsot P, Laugier R, Helbert T, Coumaros D, Scoazec JY, Mion F, Saurin JC, Societe Francaise d’Endoscopie D (2014) Endoscopic papillectomy for early ampullary tumors: long-term results from a large multicenter prospective study. Endoscopy 46:127–134
Alvarez-Sanchez MV, Oria I, Luna OB, Pialat J, Gincul R, Lefort C, Bourdariat R, Fumex F, Lepilliez V, Scoazec JY, Salgado-Barreira A, Lemaistre AI, Napoleon B (2017) Can endoscopic papillectomy be curative for early ampullary adenocarcinoma of the ampulla of Vater? Surg Endosc 31:1564–1572
Li S, Wang Z, Cai F, Linghu E, Sun G, Wang X, Meng J, Du H, Yang Y, Li W (2019) New experience of endoscopic papillectomy for ampullary neoplasms. Surg Endosc 33:612–619
Yamaguchi K, Enjoji M, Kitamura K (1990) Endoscopic biopsy has limited accuracy in diagnosis of ampullary tumors. Gastrointest Endosc 36:588–592
Menzel J, Poremba C, Dietl KH, Bocker W, Domschke W (1999) Tumors of the papilla of Vater–inadequate diagnostic impact of endoscopic forceps biopsies taken prior to and following sphincterotomy. Ann Oncol 10:1227–1231
Rodriguez C, Borda F, Elizalde I, Jimenez Perez FJ, Carral D (2002) How accurate is preoperative diagnosis by endoscopic biopsies in ampullary tumours? Rev Esp Enferm Dig 94:585–592
Elek G, Gyori S, Toth B, Pap A (2003) Histological evaluation of preoperative biopsies from ampulla vateri. Pathol Oncol Res 9:32–41
Grobmyer SR, Stasik CN, Draganov P, Hemming AW, Dixon LR, Vogel SB, Hochwald SN (2008) Contemporary results with ampullectomy for 29 “benign” neoplasms of the ampulla. J Am Coll Surg 206:466–471
Kim HN, Kim KM, Shin JU, Lee JK, Lee KT, Lee KH, Kim KM, Lim JH (2013) Prediction of carcinoma after resection in subjects with ampullary adenomas on endoscopic biopsy. J Clin Gastroenterol 47:346–351
Laleman W, Verreth A, Topal B, Aerts R, Komuta M, Roskams T, Van der Merwe S, Cassiman D, Nevens F, Verslype C, Van Steenbergen W (2013) Endoscopic resection of ampullary lesions: a single-center 8-year retrospective cohort study of 91 patients with long-term follow-up. Surg Endosc 27:3865–3876
Nam K, Song TJ, Kim RE, Cho DH, Cho MK, Oh D, Park DH, Lee SS, Seo DW, Lee SK, Kim MH, Baek S (2018) Usefulness of argon plasma coagulation ablation subsequent to endoscopic snare papillectomy for ampullary adenoma. Dig Endosc 30:485–492
Acknowledgements
The authors thank the Korean Society of Gastrointestinal Research for allowing us to use the clinical data of the South Korean cohort for AoV tumors.
Funding
This study was supported by a grant from the Korean Society of Gastrointestinal Cancer Research (2021).
Author information
Authors and Affiliations
Contributions
Study concept and design: SBY, MKJ, YSL, and JHH. Data acquisition: SBY, MKJ, YSL, JKP, DKJ, JML, HSL, DWS, and JCL. Data analysis and interpretation: SBY, MKJ, and YSL. Drafting of the manuscript: SBY and YSL. Critical revision of the manuscript for important intellectual content: MKJ and JJH. Statistical analysis: SBY and YSL. Obtained funding: JJH. Administrative, technical, or material support: JKP, DKJ, JML, HSL, and JCL. Study supervision: MKJ, JKP, and JHH. Approval of final manuscript: all authors.
Corresponding author
Ethics declarations
Disclosure
Seung Bae Yoon, Min Kyu Jung, Yoon Suk Lee, Joo Kyung Park, Dong Kee Jang, Jae Min Lee, Hee Seung Lee, Dong Woo Shin, Jong-Chan Lee, and Jin-Hyeok Hwang have no conflict of interest or financial ties to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
464_2022_9856_MOESM2_ESM.tif
For patients with ampullary AC, OS (A) and RFS (B) between EP alone and EP surgery group. EP, endoscopic papillectomy; OS, overall survival; RFS, recurrence-free survival. Supplementary file2 (TIF 2087 KB)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yoon, S.B., Jung, M.K., Lee, Y.S. et al. Long-term outcomes of endoscopic papillectomy for ampullary adenoma with high-grade dysplasia or adenocarcinoma: a propensity score-matched analysis. Surg Endosc 37, 3522–3530 (2023). https://doi.org/10.1007/s00464-022-09856-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-022-09856-w